Related Experiment Video
Updated: Jan 1, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNA-613: A novel tumor suppressor in human cancers
1The First Clinical Medicine College, Nanjing Medical University, Nanjing, 211166, China; Cytoskeleton Research Group, Nanjing Medical University, Nanjing, 211166, China.
Abstract:
MicroRNAs (miRNAs) are short-chain non-coding RNAs that act as critical roles in malignant tumorigenesis via regulating the expression of tumor-associated genes through post-transcriptional level based on specific binding to their target genes. MicroRNA-613 (miR-613) is a new-found miRNA and emerging evidences show that miR-613 participates in multiple physiological and pathological processes. Recent studies have exhibited that miR-613 is abnormally expressed in a variety of cancers and act as important roles in the progression of cancers. To be specific, miR-613 is generally identified as a tumor suppressor in multiple cancers. In this review, we systematically summarize the roles of miR-613 and highlight the potential correlation between miR-613 expression and clinical features in human cancers.
Related Concept Videos
MicroRNAs
MicroRNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

